2017-2020 Ph.D(Biopharmaceutics & Pharmaceuticaltechnology),University of Paris Saclay, France
2019-2019 Summer School “European universityconsortium forpharmaceutical science”, University of Helsinki, Finland
2015-2016 Master “Cell, Tissue and Gene Biotherapies” Facultyof Medicine, University of Paris Est, France
2013-2015 MBA“Management’’University of Sindh, Pakistan
2012-2013 M.Phil (Part 1)(Pharmaceutics) “Doctor of Pharmacy”Faculty of Pharmacy,University of Sindh
2007-2011 Pharm.D “Doctor of Pharmacy”Faculty of Pharmacy,University of Sindh, Pakistan
Dr. Zeeshan Ahmed is a distinguished academic and researcher in the field of Pharmacy, currently serving as an Associate Professor at Iqra University, North Karachi, Pakistan. With a background in Biopharmaceutics and Pharmaceutical Technology, his expertise lies in enhancing drug delivery through innovative methods. His academic journey is marked by a Ph.D. from the University of Paris Saclay, France, specializing in Biopharmaceutics and Pharmaceutical Technology. Additionally, he holds dual master’s degrees in Pharmaceutics and Biotherapy, along with an MBA in General Management.
Dr. Zeeshan research experience is extensive and diverse, encompassing areas such as the synthesis and characterization of nanoformulations, nanofabrication, and the imaging behavior of nanoparticles in biological media. His work in preclinical and animal experiments is particularly notable, contributing significantly to the field. This multifaceted expertise is complemented by his role as a peer reviewer for international journals, highlighting his commitment to advancing pharmaceutical sciences.
His education also includes a Summer School at the University of Helsinki, Finland, and a Master’s degree from the University of ParisEst, France, focusing on Cell, Tissue, and Gene Biotherapies. His Pharmacy education was completed at the University of Sindh, Pakistan.
Professionally, his experience ranges from academic positions at Iqra University to research internships in France, focusing on drug delivery and therapeutic innovation. He has also engaged in research internships at the Institute Mondor for Biomedical Research and the Cancer-research Institute and European Cancer Centre, demonstrating his diverse research interests and capabilities.
His skill set is comprehensive, covering areas like imaging techniques, physicochemical analysis, pharmaceutics, molecular biology, microbiology, and pharmacology. His proficiency in these areas is evident in his publications and presentations at scientific conferences and congresses. His research outputs, both in thesis publications and other publications, have contributed valuable insights into pharmaceutical sciences.
Zeeshan Ahmed is a highly accomplished and versatile professional in the field of pharmaceutical sciences, with a rich academic background, extensive research experience, and a commitment to advancing knowledge and practice in his field. His work stands as a testament to his dedication and skill, making him a valuable asset to the academic and research community.
2024: Knowledge, attitude, and awareness of breast cancer among non-medical female undergraduate students in karachi, Pakistan. Rawal Medical Journal: Vol. 49, No. 2, Apr-Jun-2024.
2024: Understanding the interplay between surface properties and the aspect ratio of ellipsoidalnanomaterials. doi:10.1016/j.colsurfa.2023.132680. Colloids and Surfaces A: Physicochemical and Engineering.
2023: Effectiveness of Obturator Nerve Block in Preventing Adductor Reflex During Transurethral Resection of Bladder Tumor. RADS Journal of Pharmacy and Allied Health Sciences, eISSN: 2958-7913; p,ISSN: 2958-7905, ADS J.Pharm.Allied Health Sci. Vol. 1 No. 2, 2023: 425.
2023: Prescribing trends of amoxicillin, ceftriaxone, and moxifloxacin across different districts of karachi, pakistan. DOI: 10.38106. Liaquat Medical Research Journal. LMRJ.2023.5.3-04. LMRJ Volume 5 Issue 3.
2023: A Clinical Trial Of Virtual Reality In Physical Therapy For Burn Patients: Effects On Pain Perception.Biological and Clinical Sciences Research Journal, eISSN: 2708-2261; p,ISSN: 2958-4728, www.bcsrj.com, DOI:https://doi.org/10.54112/bcsrj.v2023i1.425 Biol. Clin. Sci. Res. J., Volume, 2023: 425.
2023:Evaluation ofimpactofhyperglycemia and hyponatremia onclinical outcome of acute stroke. LMRJ Volume 5Issue 02, 2023. Journal: Liaquat Medical Research Journal DOI: 10.38106/LMRJ.2023.5.2- 04.
2023:The role of Cepharanthine asan anti-atherosclerotic agent in rats. Pak. J. Pharm. Sci., Vol.:36, No.4, July 2023,pp.1073-1077 2023. doi.org/10.36721/PJPS. 2023.36.4.REG.1073-1077.1.
2023: Quality Analysisof Various Nationaland International Brands of Glimepirides Available inPakistan. (2023) P J MH S Vol. 17, No. 02, February, 2023 DOI: https://doi.org/10.53350/pjmhs2023172714.
2023: Knowledgeand Awarenessof Community People on Dengue Fever Infection: ACross-Sectional Study (2023) P JM H S Vol. 17, No. 02, February, 2023. DOI: https://doi.org/10.53350/pjmhs2023172711 .
2023: Assessmentof Frequencyand Severity of ADRS Related with CHOP Therapyin Lymphoma Treatment. (2023) P JM H S Vol. 17, No. 4, April, 2023. DOI: https://doi.org/10.53350/pjmhs2023174370 .
2022: Cepharanthine Action in Preventing Obesityand Hyperlipidemia in Rats ona High-Fat High SucroseDiet.SaudiPharmaceuticalJournal.(2022)https://doi.org/10.1016/j.jsps.
2022.09.013.[IF:4.562]
2022: The Potential of Sorafenib inPreventing Metabolic Syndrome in Rats Fed a High-Fat High-Sucrose Diet. JournalofHunan UniversityNatural Sciences Vol 49,No 8 (2022). https://doi.org/10.55463/issn.1674- 2974.49.8.13.
2022: Assesment of empagliflozin add-on therapy to metformin and glimepiride in patient with inadequatelycontrolled type2 diabetes mellitus. https://doi.org/10.36721/PJPS. 2022.35.6.SP.1733-1738.1.
2022: Assessmentof COVID-19 vaccine booster doseacceptance, reluctance and concerns among elderlydiabetes patients in Pakistan, PakJ.ofPharma:Sciences.doi.org/10.36721/PJPS.2022.35.4.SP.1269-1274.1.
2021: Shape stability of ellipsoidal nanomaterials prepared by physical deformation,International Journal of Pharmaceutics, Volume609, 20 November 2021 https://doi.org/10.1016/j.ijpharm.2021.121178.
2018:New insights onn the structure of hexagonallsy faceted platelets from hydrophobically modified chitosanand α-cyclodextrine, IntJPharm, Volume548, Issue1, Pages23-33 2018. doi: 10.1016/j.ijpharm.2018.06.035.
2017: Myalgiaassociation with atorvastatin, rosuvastatinandsimvastatin, Medical Forum, Page 98-101 Vol 28, No.3March 2017 ISSN 1029-385X.
